Research Topics
| N BergemannSummaryAffiliation: University of Heidelberg Country: Germany Publications
| Collaborators
|
Detail Information
Publications
High bone turnover but normal bone mineral density in women suffering from schizophreniaN Bergemann
Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany
Psychol Med 38:1195-201. 2008..This study was undertaken because empirical evidence from larger patient cohorts is limited and the data are still controversial...
Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trialNiels Bergemann
Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany
Schizophr Bull 34:1172-81. 2008..The issue of estrogen-dependent neuropsychological performance could be highly relevant because women with schizophrenia frequently suffer from hypoestrogenism...
High clozapine concentrations in leukocytes in a patient who developed leukocytopeniaNiels Bergemann
Department of General Psychiatry, University of Heidelberg Voss Str 4, Heidelberg, Germany
Prog Neuropsychopharmacol Biol Psychiatry 31:1068-71. 2007..It is assumed that changes or abnormalities of clozapine uptake at the cell membrane might play a role in the development of clozapine-induced leukocytopenia and/or agranulocytosis...- Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophreniaNiels Bergemann
Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany
Psychol Med 37:1427-36. 2007..The aim of the present study was to evaluate the association between menstrual cycle and/or estrogen levels and psychotic symptoms in a sample of women with schizophrenia... - Plasma amisulpride levels in schizophrenia or schizoaffective disorderN Bergemann
Department of Psychiatry, University of Heidelberg, Voss Str 4, D 69115, Heidelberg, Germany
Eur Neuropsychopharmacol 14:245-50. 2004..The results, the possible pathomechanisms and the clinical relevance are discussed. The findings need to be confirmed in larger patient samples and with a wider range of co-medications... - Asymptomatic pancreatitis associated with clozapineN Bergemann
Department of Psychiatry, University of Heidelberg, Germany
Pharmacopsychiatry 32:78-80. 1999..The monitoring of serum amylase levels during slow increase in clozapine is recommended; if leukocytosis or eosinophilia is present, the possibility of even a subclinical and asymptomatic pancreatitis should be considered... - Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patientsN Bergemann
Department of Psychiatry, University of Heidelberg, Germany
Pharmacopsychiatry 37:63-8. 2004..Very little is known about the plasma concentration in patients at various oral doses of olanzapine or about the clinically relevant interactions with co-medications... - Acute psychiatric admission and menstrual cycle phase in women with schizophreniaN Bergemann
Department of Psychiatry, Ruprecht Karls University of Heidelberg, Voss Strasse 4, D 69115 Heidelberg, Germany
Arch Womens Ment Health 5:119-26. 2002..The results are discussed in relation to the possibly underlying physiological mechanisms... - H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizuresRegina W von Einsiedel
Department of Psychiatry, Division of Neuroradiology, Ruprecht Karls University of Heidelberg, Vossstrasse 4, 69115 Heidelberg, Germany
Pharmacopsychiatry 35:152-4. 2002.... - Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled studyNiels Bergemann
Department of General Psychiatry, University of Heidelberg, Voss Str 4, D 69115 Heidelberg, Germany
Psychoneuroendocrinology 33:507-16. 2008..This is the very first study, based on estrogen intervention instead of physiological hormone changes, to examine the association between estrogen and spatial ability in women with schizophrenia... - Estrogen in the treatment of late-onset schizophreniaNiels Bergemann
J Clin Psychopharmacol 27:718-20. 2007 - Increase in plasma concentration of amisulpride after addition of concomitant lithiumNiels Bergemann
J Clin Psychopharmacol 27:546-9. 2007 - Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind studyNiels Bergemann
Department of Psychiatry, Ruprecht Karls University of Heidelberg, Voss Str 4, D 69115 Heidelberg, Germany
Schizophr Res 74:125-34. 2005..Thus, the results of our study do not confirm the hypothesis that a combined estradiol/antipsychotic therapy is superior to an antipsychotic monotherapy for relapse prevention... - Clozapine augmented with aripiprazole in 5 patients with schizophreniaFatima Abu-Tair
J Clin Psychopharmacol 26:669-71. 2006 - Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychoticsNiels Bergemann
Department of Psychiatry, University of Heidelberg, Voss Str 4, D 69115 Heidelberg, Germany
Schizophr Res 73:357-66. 2005..In addition, low levels of estrogen might have a negative effect on bone mineral density and on the cardiovascular system... - Amisulpride has no effect on plasma clozapine concentrationsNiels Bergemann
J Clin Psychopharmacol 25:494-7. 2005 - Valproate lowers plasma concentration of olanzapineNiels Bergemann
J Clin Psychopharmacol 26:432-4. 2006